|
|
|
|
|
Teisinis statusas
Patento galiojimo terminas pasibaigęs
| (51) | INT.CL.: (2006.01) |
A61P 9/00 A61K 31/135 A61K 31/137 A61P 25/00 |
| (11) | Patento numeris | 4455 |
| (13) | Dokumento rūšis | B |
| (21) | Paraiškos numeris | 97-200 |
| (22) | Paraiškos padavimo data | 1997-12-22 |
| (41) | Paraiškos paskelbimo data | 1998-09-25 |
| (45) | Patento paskelbimo data | 1999-01-25 |
| (86) | Numeris | PCT/US96/07465 |
| Data | 1996-05-22 |
| (87) | Numeris | WO 96/37199 |
| Data | 1996-11-28 |
| (30) | Numeris | Data | Šalis |
| 446439 | 1995-05-22 | US |
| (71) |
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.,
Senate House, Technion City, 32000 Haifa,
IL
TEVA PHARMACEUTICAL INDUSTRIES, LTD., Science Based Industries Campus, Har Hotzvim, P.O. Box 1142, 91010 Jerusalem, IL |
| (72) |
Moussa B. YOUDIM, IL
John P.M. FINBERG, IL Ruth LEVY, IL Jeffrey STERLING, IL David LERNER, IL Haim YELLIN, IL Alex VEINBERG, IL |
| (73) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
Science Based Industries Campus, Har Hotzvim, P. O. Box 1142, 91010 Jerusalem,
IL
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD., Senate House, Technion City, 32000 Haifa, IL |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | N-propargil-1-aminoindano R-entantiomero, jo druskų ir jo kompozicijų panaudojimas |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2015-04-22 | 20 | 347.00 EUR |
| Patento galiojimo terminas pasibaigęs | ||
| Patento panaikinimo data | 2016-05-22 |